Videos
PLENARY
Plenary I
Biological Therapy in SLE: a critical analysis of trials for clinical practice. New treatments for SLE: How were they tested, and how are they used in clinical practice?
Van Vollenhoven, Ronald
Future trials in Lupus: can treatment development be any less risky?
Merril, Joan
Lessons learned: are all failed trial due to failed treatments?
Furie, Richard
Plenary II
Evidence based induction and maintenance theraphy recommendations for lupus nephritis
Comparison of ACR and EULAR/ERA recommendations
Hahn, Bevra
Standard of Care
Houssiau, Frederic
Use of biologics
Lightstone, Liz
Plenary III
The last decade: advances in pathogenesis, diagnosis and management of neuropsychiatric lupus.
SYMPOSIUM
Basic Symposium
"Net" relevance to Lupus pathogenesis
Kaplan, Mariana
Neuropathogenic potential of anti-ribosomal P antibodies
Gonzalez, Alfonso
Epidemiologic Symposium
Lessons from lupus epidemiology around the world (Latin America / GLADEL)
Catoggio, Luis
Lessons from lupus epidemiology around the world (Europe)
Cervera, Ricard
Lessons from lupus epidemiology around the world (USA/Lumina)
Alarcón, Graciela
Pediatric Symposium
Gonadal function and preservation of reproductive fitness in juvenile systemic lupus erythematosus
Almeida Da Silva, Clovis
Therapy insight: cardiovascular disease in pediatric systemic lupus
Schanberg, Laura
Therapy of lupus nephritis in juvenile patients
Sandborg, Christy
Plenary Industry Symposium | Glaxo Smithkline
The changing face of SLE management
Masardo, Loreto
The changing face of SLE management
Catoggio, Luis
The changing face of SLE management
Van Vollenhoven, Ronald
The changing face of SLE management
Furie, Richard
The changing face of SLE management
Collins, Christopher
QUESTIONS & ANSWERS
Plenary Industry Symposium | Lilly
Clinical challenges and evidence-based solutions in the management of lupus
Cardiel, Mario
Clinical challenges and evidence-based solutions in the management of lupus
Urowitz, Murray
Clinical challenges and evidence-based solutions in the management of lupus
Petri, Michelle
Clinical challenges and evidence-based solutions in the management of lupus
Isenberg, David
Plenary Industry Symposium | Pfizer
What do we need to know about immunogenicity?
Wolbink, Gertjan
Plenary Industry Symposium | UCB
Hitting the mark in SLE care: emerging targets in response to new advances
Van Vollenhoven, Ronald
Hitting the mark in SLE care: emerging targets in response to new advances
Furie, Richard
Hitting the mark in SLE care: emerging targets in response to new advances
Petri, Michelle
Hitting the mark in SLE care: emerging targets in response to new advances
Dorner, Thomas
Hitting the mark in SLE care: emerging targets in response to new advances
QUESTIONS & ANSWERS
Genetic
Ancestral variation in SLE genetics at IRF5 and in the African-American GWAS
Harley, John
Latest GWAS in Mestizos
Alarcón Riquelme, Marta
The genetics of SLE, an update and what it means for de patient and de physician
Kimberly, Robert
INVITED LECTURE
A critical point of view of their relevance for clinical practice
Pisetsky, David
Antimalarials revisited
Ruiz-Irastorza, Guillermo
Evidences for treatment of cutaneous lupus: a dermatologist approach
Werth, Victoria
Getting beyond description: Explaining the causes of disparities by race/ethnicity in SLE
Yelin, Edward
New SLE criteria: are they better?
Petri, Michelle
Novel insights into diagnosis and treatment of antiphospholipid syndrome
Meroni, Pier Luigi
Predictors of major infections on SLE
Shoenfeld, Yehuda
Understanding the challenge of osteoporosis and low vitamin D in lupus
Pereira, Rosa
UP TO DATE
Cardiovascular risk assessment and treatment: recommendations for daily practice
Manzi, Susan
Challenges in the management of obstetric lupus patients
Levy, Roger
Current thinking about prevition, management and outcomes of the neonatal lupus syndromes
Buyon , Jill
Lupus biopsy: the nephrologist’s point of view
Lightstone, Liz
Malignancies and systemic lupus lessons from a comprehensive review
Clarke, Ann
Major contributions of SLICC group to clinical practice 20-years experience
Urowitz, Murray
THE YEAR IN REVIEW
ORAL PRESENTATIONS
Accuracy of systemic lupus international collaborating clinics classification criteria applied to juvenile systemic lupus erythematosus patients
Katsicas, María Martha
Adipokines association with clinical, laboratory and medication correlation with TNF system in SLE patients. Peliminary analysis.
Costa Duarte Lanna, Cristina
Blisibimod, an emerging subcutaneous biologic theraphy for patients with active, moderate-to-severe systemic lupus erythematosus
Scheinberg, Morton
Frequency of hematological alterations in patients with systemic lupus erythematosus and its association with vascular thrombosis – GLADEL registration
Martinez Betancur, Octavio
French registry of 189 cases of immune congenital heart block: maternal data analysis
Levesque, Kateri
Hippocampal atrophy in childhood-onset systemic lupus erythematosus
Barbosa, Rosa
Long-term outcomes of children born to women with systemic lupus erythematosus
Vinet, Evelyne
Lupus anticoagulant at first pregnancy visit is predictive of pregnancy loss
Petri, Michelle
Mortality rates among U.S. Medicaid recipients with SLE, 2000-2006
Gomez-Puerta, José
Neutrophil gelatinase associated lipocalin (NGAL/lipocalin-2) regulates the onset of serum autoantibodies in pristane induced lupus
Putterman, Chaim
Novel urine biomarkers for monitoring disease activity in juvenile lupus nephritis: a prospective longitudinal validation study
Watson, Louise
Outcomes associated with Belimumab in patients with Systemic Lupus Erithematosus (SLE) in clinical practice settings: results from OBServe study in the United States (U.S.)
Collins, Christopher
Predictive atherosclerotic risk factors at inception in a multicentre multinational cohort
Urowitz, Murray
Prevalence and clinical significance of severe infection in patients with systemic lupus erythematosus: preliminary dada from RESELLER (registry of Lupus of the Spanish Society of Rheumatology)
Pego-Reigosa, José María
Provisions of quality driven care in childhood-onset Systemic Lupus Erythematosus
Brunner, Hermine
Response to a protein challenge in patients with lupus nephritis and variable degree of glomerular or interstitial damage after maintenance therapy
Bernasconi, Amelia
Risk of myocardial infarction in patients with systemic Lupus Erithematosus: a population-based study
Avina Zubieta, Juan
Serum levels of B-Lymphocyte simulator and A proliferation inducing ligand in patients with lupus nephritis: APRIL as a candidate biomarker
Parodis, Ioannis
SLE18a, a murine 129-derived disease modifier locus on chromosome 3, regulates the expression of Ly108 isoforms in T cells
Carlucci, Francesco
SLE cardiovascular risk equation
Petri, Michelle
The granulocite signature and organ inflammation in TLR7 responsive mice is RNA and type 1 interferon dependent
Elkon, Keith
The PREDICTS panel of biomarkers is associated with 28-fold increased risk for the presence and progression of atherosclerosis in women with SLE
Mcmahon, Maureen
Which lupus trail endpoint best reflect clinical judgement or biomarker improvement?
Thanou, Aikaterini